News and Comments

ILMN AND HGSI: REASONS FOR ATYPICAL REJECTIONS OF TAKEOVERS

  Sunday, April 22, 2012

These days all the focus, the talk, the debates, and the confusion are, and will certainly continue for a while to be, about Illumina’s (ILMN) and Human Genome’s (HGSI) rejection of the acquisitions offers. The truth is that the offers were not as generous as they are said they are. More...

AFFYMAX vs. AMGEN?

  Tuesday, April 03, 2012

Affymax (AFFY) red blood growth factor drug Omontys (peginesatide) was granted FDA approval – good news for the firm. The approval is a remarkable achievement by Affymax. The firm has proven a capability developing biological products and there is no doubt that AFFY will sell the drug Omontys for patients with chronic kidney disease on dialysis, as it is dictated by the FDA.  More...


Recent Postings


Archive


Tags

Regeneron (REGN) Agenus (AGEN Anacor (ANAC) Sequenom (SQNM) Anadys (ANDS) C4 Therapeutics NEKTAR (NKTR)) Bellicum (BLCM) Theravance (THRX) Prosensa (RNA) Ionis (IONS) Genentech Rapamune Sanofi (SNA) Valeant Pharmaceuticals International (VRX) Exelixis (EXEL) Vertex (VRTX) Human Longevity (HLI) Sarepta (SRPT) Roche (ROCHE) GUARDIAN HEALTH Abbott Laboratories (ABT) Benlysta (belimumab) Gilead (GILD) ZALTRAP™ TOKAI (TKAOI) galapagos (GLPG) CompuGen (CGEN) JUNO (JUNO) Alder Biopharmaceuticals (ALDR) Agenus (AGEN) Zerenex SYNTA (SNTA) KITE (KITE) Micromet (MITI) Biocryst (BCRX) Human Genome Sciences (HGSI) Herceptin PORTOLA (PTLA) Dynavax (DVAX) ADVENTRIX (ANX) Spike Therapeutics (ONCE) ARCA (ABIO) MODERNA Idenix (IDIX) Velcade (bortezomib) Xoma (XOMA) Alnylam (ALNY) Aimmune Therapeutics (AIMT) Sanofi (SNY) Roche (RHHBY) PTC Therapeutics (PTCT) Onyx (ONXX) Telaprevir Multiple Myeloma ACADIA (ACAD) Array Pharmaceuticals (ARRY) Vitae Pharmaceuticals (VTAE) JOUNCE THERAPEUTICS (JNCE) Advaxis (ADXS) Dendreon (DNDN) SERES THERAPEUTICS (MCRB) Galena (GALE) Theravance Bio Pharma (TBPH) KERYX (KERX) Sanofi-Aventis (SAN) Cytokinetics (CYTK) Editas (EDIT) BIOMARIN (BMRN) OSI (OSIP) Ariad (ARIA) Merck (MRK) REGULUS (RGLS) ImmunoGen (IMGN) Prolor Biotech (PBTH) LEXICON (LXRX) Tysabri GlaxoSmithKline (GSK) CEMPRA (CEMP) Auspex (ASPX) ABBVIE (ABBV) NEUROCRINE (NBIX) Jazz Pharmaceuticals (JAZZ) CRISPR Therapeutics (CRSP) Pluristem (PSTI) Adaptimmune (ADAP) INNOVIVA (INVA) ISIS (ISIS) Endometrial Cancer Elan (ELN) OncoCyte (OCX) Amgen (AMGN) VANDA (VNDA) Intercept (ICPT) Global Cell Therapeutics (GBT) Intermune (ITMN) Inovio (INO) SUNESIS PHARMACEUTICALS (SNSS) Intrexon (XON) RenenxBio (RGNX) Ridaforolimus NANTKWEST (NK) IDERA (IDRA) ARGOS (ARGS) AGOS (ARGS) Mirati Therapeutics (MRTX) Ocular Therapeutix (OCUL) NOVOCURE (NVCR) HALOZYME (HALO) Ziofpharm (ZIOP) Trastuzumab-DM1 Incyte (INCY) Seattle Genetics (SGEN) AstraZeneca (AZN) Sangamo (SGMO) Illumina (ILMN) Biogen Idec (BIIB) Revlimid (lenolidamide) Bristol-Myers Squibb (BMY) AERIE PHARMACEUTICALS